1248 POSTER A Phase I Study Evaluating GDC-0941, a Pan-phosphoinositide-3 Kinase (PI3K) Inhibitor, in Patients (pts) With Advanced Solid Tumours, Multiple Myeloma, and PIK3Ca Mutant (mt) Tumours

✍ Scribed by S. Banerjee; R. Baird; B. Basu; K. Shah; N. Tunariu; V. Moreno Garcia; J. Corral; K. Mazina; G. Levy; J. de Bono

• Book ID: 117661354
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 46 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(11)70860-7